Atrás
Rango del Día
$50.19
$52.55
Rango de 52 Semanas
$22.28
$59.55
Volumen
5,972,328
Promedio 50D / 200D
$47.06
/
$32.47
Cierre Anterior
$51.38
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -7.2 | 0.4 |
| P/B | 2.3 | 2.9 |
| ROE % | -28.9 | 3.7 |
| Net Margin % | -145.2 | 3.9 |
| Rev Growth 5Y % | -42.5 | 10.0 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
Hold
$35.67
-30.4%
Low: $17.00
High: $63.00
EPS Futuro
-$6.39
Ingresos Est.
2.1 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$2.66
$1.98 – $4.35
|
6.7 B | 6 |
| FY2029 |
-$0.03
-$0.05 – -$0.02
|
5 B | 10 |
| FY2028 |
-$2.90
-$6.17 – $0.69
|
3.2 B | 15 |
Puntos Clave
Revenue declined -42.46% annually over 5 years
Debt/Equity of 0.22 — conservative balance sheet
Negative free cash flow of -2.07B
PEG of 0.19 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.23%
Capital efficient — spends only 9.88% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-42.46%
Revenue (1Y)-39.23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-28.87%
ROIC-21.82%
Net Margin-145.16%
Op. Margin-158.13%
Seguridad
Debt / Equity
0.22
Current Ratio3.29
Interest Coverage0.00
Valoración
P/E Ratio
-7.18
P/B Ratio2.34
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -39.23% | Revenue Growth (3Y) | -46.72% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -42.46% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.94B | Net Income (TTM) | -2.82B |
| ROE | -28.87% | ROA | -22.87% |
| Gross Margin | 55.35% | Operating Margin | -158.13% |
| Net Margin | -145.16% | Free Cash Flow (TTM) | -2.07B |
| ROIC | -21.82% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.22 | Current Ratio | 3.29 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.18 | P/B Ratio | 2.34 |
| P/S Ratio | 10.42 | PEG Ratio | 0.19 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 20.25B | Enterprise Value | 19.57B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.94B | 3.20B | 6.85B | 18.88B | 17.74B |
| Net Income | -2.82B | -3.56B | -4.71B | 8.36B | 12.20B |
| EPS (Diluted) | -7.26 | -9.27 | -12.34 | 20.10 | 28.29 |
| Gross Profit | 1.08B | 1.74B | 2.16B | 13.46B | 15.12B |
| Operating Income | -3.07B | -3.95B | -4.24B | 9.42B | 13.30B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12.34B | 14.14B | 18.43B | 25.86B | 24.67B |
| Total Liabilities | 3.69B | 3.24B | 4.57B | 6.74B | 10.52B |
| Shareholders' Equity | 8.65B | 10.90B | 13.85B | 19.12B | 14.15B |
| Total Debt | 1.92B | 747.00M | 1.24B | 1.20B | 916.00M |
| Cash & Equivalents | 2.60B | 1.93B | 2.91B | 3.21B | 6.85B |
| Current Assets | 6.54B | 8.10B | 10.33B | 13.43B | 16.07B |
| Current Liabilities | 1.99B | 2.21B | 3.02B | 4.92B | 9.13B |